Coherus Oncology Faces Delisting Concerns
Ticker: CHRS · Form: 8-K · Filed: Jul 3, 2025 · CIK: 1512762
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
Related Tickers: CHRS
TL;DR
CHRS might be delisted - major red flag!
AI Summary
Coherus Oncology, Inc. filed an 8-K on July 3, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the effective date of change being June 30, 2025. The company, formerly known as Coherus BioSciences, Inc., is incorporated in Delaware and based in Redwood City, CA.
Why It Matters
This filing indicates potential issues with Coherus Oncology's continued listing on a stock exchange, which could impact its stock's liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can lead to severe consequences for the company and its shareholders.
Key Numbers
- 001-36721 — Commission File Number (Identifies the company's filing history with the SEC.)
- 27-3615821 — IRS Employer Identification Number (Tax identification number for the company.)
Key Players & Entities
- Coherus Oncology, Inc. (company) — Registrant
- Coherus BioSciences, Inc. (company) — Former company name
- June 30, 2025 (date) — Date of earliest event reported
- July 3, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Redwood City, CA (location) — Business address city and state
FAQ
What specific listing rule or standard has Coherus Oncology failed to satisfy?
The filing does not specify the exact rule or standard that Coherus Oncology has failed to satisfy, only that a notice has been issued.
What is the expected timeline for the delisting process, if it proceeds?
The filing indicates the date of change as June 30, 2025, but does not provide a specific timeline for the delisting process itself.
Has Coherus Oncology taken any steps to address the listing deficiency?
The provided text of the 8-K does not mention any specific steps taken by Coherus Oncology to address the listing deficiency.
What is the significance of the former company name, Coherus BioSciences, Inc.?
The filing notes that Coherus Oncology, Inc. was formerly known as Coherus BioSciences, Inc., indicating a name change occurred.
Where is Coherus Oncology, Inc. incorporated and headquartered?
Coherus Oncology, Inc. is incorporated in Delaware and its business address is in Redwood City, CA.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding Coherus Oncology, Inc. (CHRS).